Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel L Price

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery|August 29, 2024
Cancer in Patients With Incidental Asymmetric Oropharynx Positron Emission Tomography UptakeMichael F Armstrong, Brian J Burkett, Thomas J O'Byrne, et al.
Medical Science Educator|June 18, 2024
Creating an Undergraduate Research Program in Otolaryngology-Head and Neck Surgery (Oto-HNS) for Students Underrepresented in MedicineDontre' M Douse, Patricia Timothee, Jessica M O'Neill, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 14, 2025
Postoperative ctHPVDNA Kinetics in Patients With HPV-Related Oropharyngeal CancerLinda X Yin, Cecelia M Hidalgo, Aaron W Bogan, et al.
International Forum of Allergy & Rhinology|December 3, 2022
Sinonasal mucosal melanoma: An analysis of treatment-related adverse events and associated factorsBrian J Johnson, Ruifeng Guo, Eric J Moore, et al.
Oral Oncology|July 27, 2020
T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinomaKathryn M Van Abel, David M Routman, Eric J Moore, et al.
Viruses|April 27, 2026
Induction Cisplatin, Docetaxel, and 5-Fluorouracil Versus Platinum Doublet in Human Papillomavirus-Associated Oropharyngeal CancerAshwin Ganti, Patrick W McGarrah, Harry Fuentes Bayne, et al.
Oral Oncology|November 2, 2025
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patientsAgnes Q Zhu, Claire E Cassianni, Travis Haller, et al.
Advances in Radiation Oncology|July 11, 2022
The Number of Radiographically Positive Lymph Nodes Further Stratifies Patient Survival Among Clinical N1 Patients With Human Papillomavirus-Associated Oropharyngeal CancerRoman O Kowalchuk, Kathryn M Van Abel, Adam B Sauer, et al.
Oral Oncology|January 11, 2024
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancerAisha A Aden, Felicia O Olawuni, Chadi N Abdel-Halim, et al.
Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
JAMA Otolaryngology-- Head & Neck Surgery|August 29, 2024
Cancer in Patients With Incidental Asymmetric Oropharynx Positron Emission Tomography UptakeMichael F Armstrong, Brian J Burkett, Thomas J O'Byrne, et al.
Medical Science Educator|June 18, 2024
Creating an Undergraduate Research Program in Otolaryngology-Head and Neck Surgery (Oto-HNS) for Students Underrepresented in MedicineDontre' M Douse, Patricia Timothee, Jessica M O'Neill, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 14, 2025
Postoperative ctHPVDNA Kinetics in Patients With HPV-Related Oropharyngeal CancerLinda X Yin, Cecelia M Hidalgo, Aaron W Bogan, et al.
International Forum of Allergy & Rhinology|December 3, 2022
Sinonasal mucosal melanoma: An analysis of treatment-related adverse events and associated factorsBrian J Johnson, Ruifeng Guo, Eric J Moore, et al.
Oral Oncology|July 27, 2020
T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinomaKathryn M Van Abel, David M Routman, Eric J Moore, et al.
Viruses|April 27, 2026
Induction Cisplatin, Docetaxel, and 5-Fluorouracil Versus Platinum Doublet in Human Papillomavirus-Associated Oropharyngeal CancerAshwin Ganti, Patrick W McGarrah, Harry Fuentes Bayne, et al.
Oral Oncology|November 2, 2025
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patientsAgnes Q Zhu, Claire E Cassianni, Travis Haller, et al.
Advances in Radiation Oncology|July 11, 2022
The Number of Radiographically Positive Lymph Nodes Further Stratifies Patient Survival Among Clinical N1 Patients With Human Papillomavirus-Associated Oropharyngeal CancerRoman O Kowalchuk, Kathryn M Van Abel, Adam B Sauer, et al.
Oral Oncology|January 11, 2024
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancerAisha A Aden, Felicia O Olawuni, Chadi N Abdel-Halim, et al.
Thyroid : Official Journal of the American Thyroid Association|October 10, 2019
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid CancerAshish V Chintakuntlawar, Jun Yin, Robert L Foote, et al.
Pageof 15